Wallace Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.84 M
as on 16-11-2024
- Company Age 28 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.25 Cr
as on 16-11-2024
- Revenue 27.12%
(FY 2023)
- Profit 73.35%
(FY 2023)
- Ebitda 97.71%
(FY 2023)
- Net Worth 22.49%
(FY 2023)
- Total Assets 30.27%
(FY 2023)
About Wallace Laboratories
- CIN/LLPIN
U33112GA1996PTC002077
- Company No.
002077
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Wallace Laboratories Private Limited offer?
Wallace Laboratories Private Limited offers a wide range of products and services, including Vials and Ampoules, Glass Vials, Ampoule.
Who are the key members and board of directors at Wallace Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Pinto  | Managing Director | 19-Aug-2021 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Cesar Menezes | Director | 15-Mar-2006 | Current |
| Maria Menezes | Director | 15-Mar-2006 | Current |
| Rashmi Menezes | Director | 19-Aug-2021 | Current |
| Rajashekhar Basanagouda | Director | 23-May-2016 | Current |
Financial Performance of Wallace Laboratories.
Wallace Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.12% increase. The company also saw a substantial improvement in profitability, with a 73.35% increase in profit. The company's net worth Soared by an impressive increase of 22.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wallace Laboratories?
In 2021, Wallace Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wallace Pharmaceuticals Private LimitedActive 56 years 10 monthsCesar Menezes, Maria Menezes and 2 more are mutual person
Indi Pharma Private LimitedActive 40 years 11 monthsCesar Menezes and Maria Menezes are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 29 Mar 2006 | ₹3.00 Cr | Satisfied |
Bank Of Baroda Creation Date: 28 Mar 2003 | ₹2.25 Cr | Satisfied |
How Many Employees Work at Wallace Laboratories?
Wallace Laboratories has a workforce of 101 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wallace Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wallace Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
